Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Platelet Heterogeneity in Myeloproliferative Neoplasms.

Arteriosclerosis, thrombosis, and vascular biology - 1 Nov 2021

Thomas Sally, Krishnan Anandi

Abstract excerpt

Myeloproliferative neoplasms (MPNs) are a group of malignant disorders of the bone marrow where a dysregulated balance between proliferation and differentiation gives rise to abnormal numbers of mature blood cells. MPNs encompass a spectrum of disease entities with progressively more severe clinical features, including complications with thrombosis and hemostasis and an increased propensity for transformation to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Blood Coagulation
Share to Blood Platelets

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Molecular Targeted Therapy

Share to Myeloproliferative Disorders

Share to Platelet Activation

Share to Platelet Aggregation Inhibitors

Share to Thrombopoiesis

Source

Open in PubMed Open full text

Identifiers

PMID: 34615371
DOI: 10.1161/ATVBAHA.121.316373
PMCID: PMC8551046

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Platelet Heterogeneity in Myeloproliferative Neoplasms.PMID 34615371Read ↗

Platelet proteo-transcriptomic profiling validates mediators of thrombosis and proteostasis in patients with myeloproliferative neoplasmsSemantic proximity Read ↗

Clonal Megakaryocyte Dysplasia with Isolated Thrombocytosis Is a Distinct Myeloproliferative Neoplasm Phenotype.Semantic proximity Read ↗

Novel Pathophysiological Mechanisms of Thrombosis in Myeloproliferative Neoplasms.Semantic proximity Read ↗

[Clinical management of familial platelet disorder with associated myeloid malignancies: at the crossroads of hematology and clinical genetics].Semantic proximity Read ↗

Heterogeneity in myeloproliferative neoplasms: Causes and consequencesSemantic proximity Read ↗

Contributions of bone marrow monocytes/macrophages in myeloproliferative neoplasms with JAK2V617F mutation.Semantic proximity Read ↗

Increased bleeding and thrombosis in myeloproliferative neoplasms mediated through altered expression of inherited platelet disorder genesSemantic proximity Read ↗

Beyond the JAK2 mutation: The inflammasome, clonal stability, and the thrombotic niche in myeloproliferative neoplasms.Semantic proximity Read ↗

Platelet transcriptome identifies progressive markers and potential therapeutic targets in chronic myeloproliferative neoplasmsSemantic proximity Read ↗

Characterization of Cellular Heterogeneity and an Immune Subpopulation of Human MegakaryocytesSemantic proximity Read ↗

Philadelphia-Negative MPN: A Molecular Journey, from Hematopoietic Stem Cell to Clinical Features.Semantic proximity Read ↗

Clinical insights into the origins of thrombosis in myeloproliferative neoplasms.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.